SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-013774
Filing Date
2022-01-20
Accepted
2022-01-20 16:05:35
Documents
14
Period of Report
2022-01-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d477760d8k.htm   iXBRL 8-K 27981
2 EX-99.1 d477760dex991.htm EX-99.1 6786
6 GRAPHIC g477760snap0001.jpg GRAPHIC 8717
  Complete submission text file 0001193125-22-013774.txt   175570

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA annx-20220119.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20220119_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20220119_pre.xml EX-101.PRE 11709
8 EXTRACTED XBRL INSTANCE DOCUMENT d477760d8k_htm.xml XML 3469
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 22542372
SIC: 2834 Pharmaceutical Preparations